Publikationen von Matthias Geyer

Bergbrede, T.; Chuky, N.; Schoebel, S.; Blankenfeldt, W.; Geyer, M.; Fuchs, E.; Goody, R. S.; Barr, F.; Alexandrov, K.: Biophysical Analysis of the Interaction of Rab6a GTPase with Its Effector Domains. Journal of Biological Chemistry 284 (5), 1, S. 2628 - 2635 (2009)

Anand, K.; Schulte, A.; Vogel-Bachmayr, K.; Scheffzek, K.; Geyer, M.: Structural insights into the Cyclin T1-Tat-TAR RNA transcription activation complex from EIAV. Nature Structural & Molecular Biology 15 (12), 1, S. 1287 - 1292 (2008)

Hannemann, S.; Madrid, R.; Stastna, J.; Kitzing, T.; Gasteier, J.; Schönichen, A.; Bouchet, J.; Jimenez, A.; Geyer, M.; Grosse, R. et al.; Benichou, S.; Fackler, O. T.: The Diaphanous-related Formin FHOD1 Associates with ROCK1 and Promotes Src-dependent Plasma Membrane Blebbing. The Journal of Biological Chemistry 283 (41), 1, S. 27891 - 29903 (2008)

Schulte, A.; Stolp, B.; Schönichen, A.; Pylypenko, O.; Rak, A.; Fackler, O. T.; Geyer, M.: The Human Formin FHOD1 Contains a Bipartite Structure of FH3 and GTPase-Binding Domains Required for Activation. Structure 16 (9), 1, S. 1313 - 1323 (2008)

Vaz, E.; Pomerantz, W. C.; Geyer, M.; Gellman, S. H.; Brunsveld, L.: Comparison of Design Strategies for Promotion of β-Peptide 14-Helix Stability in Water. ChemBioChem 9 (14), 1, S. 2254 - 2259 (2008)

Jadlowsky, J. K.; Nojima, M.; Schulte, A.; Geyer, M.; Okamoto, T.; Fujinaga, K.: Dominant negative mutant Cyclin TI proteins inhibit HIV transcription by specifically degrading Tat. Retrovirology 5, 1, S. 63 - 74 (2008)

Pylypenko, O.; Schönichen, A.; Ludwig, D.; Ungermann, C.; Goody, R. S.; Rak, A.; Geyer, M.: Farnesylation of the SNARE Protein Ykt6 Increases Its Stability and Helical Folding. Journal of Molecular Biology 377 (5), 1, S. 1334 - 1345 (2008)

Brügger, B.; Krautkrämer, E.; Tibroni, N.; Munte, C. E.; Rauch, S.; Leibrecht, I.; Glass, B.; Breuer, S.; Geyer, M.; Kräusslich, H.-G. et al.; Kalbitzer, H. R.; Wieland, F. T.; Fackler, O. T.: Human Immunodeficiency Virus Type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains. Retrovirology 4, 70, S. 1 - 12 (2007)

Dames, S. A.; Schönichen, A.; Schulte, A.; Barboric, M.; Peterlin, B. M.; Grzesiek, S.; Geyer, M.: Structure of the Cyclin T binding domain of Hexim1 and molecular basis for its recognition of P-TEFb. Proceedings of the National Academy of Sciences of the United States of America 104 (36), 1, S. 14312 - 14317 (2007)

Anand, K.; Schulte, A.; Fujinaga, K.; Scheffzek, K.; Geyer, M.: Cyclin Box Structure of the P-TEFb Subunit Cyclin T1 Derived from a Fusion Complex with EIAV Tat. Journal of Molecular Biology 370 (5), 1, S. 826 - 836 (2007)

Barboric, M.; Yik, J. H. N.; Czudnochowski, N.; Yang, Z.; Chen, R.; Contreras, X.; Geyer, M.; Peterlin, B. M.; Zhou, Q.: Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription. Nucleic Acids Research 35 (6), 1, S. 2003 - 2012 (2007)

Mangino, G.; Percario, Z. A.; Fiorucci, G.; Vaccari, G.; Manrique, S.; Romeo, G.; Federico, M.; Geyer, M.; Affabris, E.: In Vitro Treatment of Human Monocytes/Macrophages with Myristoylated Recombinant Nef of Human Immunodeficiency Virus Type 1 Leads to the Activation of Mitogen-Activated Protein Kinases, IκB Kinases, and Interferon Regulatory Factor 3 and to the Release of Beta Interferon. Journal of Virology 81 (6), 1, S. 2777 - 2791 (2007)

Schulte, A.; Rak, A.; Pylypenko, O.; Ludwig, D.; Geyer, M.: Purification, crystallization and preliminary structural characterization of the N-terminal region of the human formin-homology protein FHOD1. Acta Crystallographica Section F: Structural Biology and Crystallization Communications F63, 1, S. 878 - 881 (2007)

Dames, S. A.; Schönichen, A.; Grzesiek, S.; Geyer, M.: NMR assigment of the Cyclin T-binding domain of human Hexim1. Journal of Biomolecular NMR 36 (Supplement 5), 1, S. 39 - 39 (2006)

Giese, S. I.; Woerz, I.; Homann, S.; Tibroni, N.; Geyer, M.; Fackler, O. T.: Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1_SF2 Nef. Virology 355 (2), 1, S. 175 - 191 (2006)

Lehmann, M. H.; Walter, S.; Ylisastigui, L.; Striebel, F.; Ovod, V.; Geyer, M.; Gluckman, J. C.; Erfle, V.: Extracellular HIV-1 Nef increases migration of monocytes. Experimental Cell Research 312 (18), 1, S. 3659 - 3668 (2006)

Schönichen, A.; Alexander, M.; Gasteier, J. E.; Cuesta, F. E.; Fackler, O. T.; Geyer, M.: Biochemical Characterization of the Diaphanous Autoregulatrory Interaction in the Formin Homology Protein FHOD1. Journal of Biological Chemistry 281 (8), 1, S. 5084 - 5093 (2006)

Breuer, S.; Gerlach, H.; Kolaric, B.; Urbanke, C.; Opitz, N.; Geyer, M.: Biochemical Indication for Myristoylation-Dependent Conformational Changes in HIV-1 Nef. Biochemistry 45 (7), 1, S. 2339 - 2349 (2006)

Mandic, R.; Schamberger, C. J.; Müller, J. F.; Geyer, M.; Zhu, L.; Carey, T. E.; Grénman, R.; Dünne, A. A.; Werner, J. A.: Reduced Cisplatin Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines Correlates with Mutations Affecting the COOH-Terminal Nuclear Localization Signal of p53. Clinical Cancer Research 11 (19), 1, S. 6845 - 6852 (2005)

Schulte, A.; Czudnochowski, N.; Barboric, M.; Schönichen, A.; Blazek, D.; Peterlin, B. M.; Geyer, M.: Identification of a Cyclin T-Binding Domain in Hexim1 and Biochemical Analysis of Its Binding Competition with HIV-1 Tat. Journal of Biological Chemistry 280 (26), 1, S. 24968 - 24977 (2005)